A rrhythmogenic cardiomyopathy (AC) is a hereditary cardiac condition characterized by progressive replacement of the myocardium with fibrous and fatty tissue causing the development of ventricular aneurysms and chamber dilatation. 1, 2 The histological changes act as substrates for ventricular arrhythmias which may explain that the condition is a frequent cause of sudden cardiac death. 3 The disease expression is heterogeneous and associated with isolated right, left, or biventricular involvement. 4
of cardiomyocytes provide the fundament for a stable electric conduction system in the myocardium. 13 Furthermore, changes in PKP2 expression may also influence gene transcription, cell differentiation, and apoptosis through regulation of specific signaling pathways. 14 PKP2 protein expression has until now only been investigated in a limited number of genotyped patients because it is difficult to obtain sufficient amounts of myocardial tissue for protein expression studies. 9, 15, 16 These studies have indicated that carriers of pathogenic mutations in the PKP2 gene have reduced myocardial PKP2 protein expression. In addition, in vitro expression studies of PKP2 mutations have shown protein instability. [17] [18] [19] Collectively, these studies indicated that PKP2 haploinsufficiency is a part of the disease mechanism in AC.
Desmosomal protein complexes help to maintain mechanical strength and integrity in a variety of tissues including the myocardium and the epidermis. Because keratinocytes express all cardiac isoforms of desmosomal proteins, we hypothesized that changes in myocardial expression of desmosomal proteins are mirrored by similar changes in keratinocytes. 20 To test this hypothesis, we investigated desmosomal protein expression in an explanted heart from a patient with AC carrying digenic mutations in PKP2 and DSG2 and compared the results with the expression of corresponding proteins in keratinocytes of the same individual. In addition, we investigated 9 different disease-associated PKP2 mutations in keratinocytes obtained from patients with AC and correlated the results to PKP2 expression in endomyocardial biopsies from the same individuals.
Methods
An expanded methods section is available in the Data Supplement.
Study Population
The study cohort consisted of 71 patients with a definite or possible diagnosis of AC referred for clinical and genetic evaluation in a dedicated cardiomyopathy clinic at Aarhus University Hospital, Denmark, from 2006 to 2011. Index patients were diagnosed with AC in accordance with recent guidelines. 21 First-degree relatives were invited for clinical and genetic assessment, and subsequent cascade genetic testing was initiated in other family members if genetic variants with a possible disease association had been detected. The local ethics committee approved the study (protocol No. 20080091) , and informed consent was obtained from all participants.
Genetic Analysis
Mutation analysis was performed in all index patients by dideoxy sequencing of all exons and flanking intron-exon boundaries in 5 desmosomal genes: PKP2, DSP, DSG2, DSC2, and JUP as described previously. 5 Sequence variants were considered to be disease associated if they were absent in 210 Danish control chromosomes and in >10 000 control chromosomes from the NHLBI Exome Sequencing Project 22 and met 1 or several of the following criteria: (1) were predicted to introduce a premature termination codon (PTC) in the reading frame, (2) were predicted to cause abnormal splicing or deletions, or (3) were shown to segregate with an AC phenotype in this or previous family studies. 23 Coding variants that did not fulfill these criteria were considered to be of unknown significance if present in control alleles with a minor allele frequency ≤0.1%, or otherwise classified as polymorphisms.
Primary Keratinocyte Cultures
Primary keratinocytes were harvested from punch skin biopsies obtained from mutation carriers and wild-type (WT) individuals and were cultured as described previously. 5, 24 In brief, keratinocytes were separated from the dermis by proteolytic treatment of the biopsies with trypsin enzyme solution. The keratinocytes were transferred to culture flasks and cultured in FAD medium on a confluent layer of γirradiated J2 3T3 mouse fibroblast feeder cells. The feeder cells were dislodged when the cells had reached 80% to 90% confluence, and the primary keratinocytes were subcultivated in large culture flasks with CNT-57 Epidermal Keratinocyte Media (CELL'n'TEC) supplemented with 5 μg/mL gentamicin. Cultures were inspected daily by phasecontrast microscopy to assess contamination and confluence. Because the study focused on desmosomal proteins incorporated in desmosomal junctions, the formation of desmosomes in confluent keratinocyte monolayers was induced by raising the concentration of calcium in the culture media from 0.07 to 1.25 mmol/L. 25 The cells were harvested 48 hours later. Third passage cells were used in all experiments.
PKP2 Gene Expression Analysis
The relative gene expression of PKP2 in cultured keratinocytes was investigated by quantitative reverse transcriptase polymerase chain reaction using TaqMan probes against the PKP2 and β-actin transcripts. 26 RNA extraction, cDNA synthesis, and quantitative reverse transcriptase polymerase chain reaction were made in triplicates of each individual.
Western Blotting
PKP2 and DSG2 protein expression was investigated by Western blotting (WB) in cultured keratinocytes. In brief, keratinocyte pellets were lysed, and cytoskeletal and cytoplasmic proteins were fractionated by detergent extraction. 24 Equal amounts of extracted proteins were separated by SDS-PAGE and blotted onto polyvinylidene fluoride membranes. The blots were incubated with antibodies against PKP2, DSG2, DSC2, and β-actin. The expression of target proteins was calculated from dilution curves and was normalized to the expression of ACTB. 24 In addition, snap-frozen myocardial tissue obtained from the septum of the explanted heart of patient 68/II-1 was available for WB. The expression of the junctional proteins PKP2, DSG2, DSP, JUP, desmin, α-actinin, N-cadherin, β-catenin, and connexin 43 was normalized to the amount of myosin heavy chain and determined by semiquantitative WB as previously described. 27 Cardiac tissue from 2 nonfailing donor hearts served as controls.
Investigation of PKP2 and DSG2 Protein Expression by Nano-Liquid Chromatography Tandem Mass Spectrometry
The quantity of PKP2 and DSG2 in cytoskeletal protein fractions in keratinocytes of mutation carriers and WT controls was quantified by nano-liquid chromatography tandem mass spectrometry (nLC-MS). 26 In brief, cytoskeletal proteins were extracted from keratinocytes and separated by SDS-PAGE. Gel pieces containing proteins migrating between 75 to 100 and 120 to 150 kDa were isolated, and the proteins were reduced, alkylated, and proteolytically cleaved with trypsin. The resulting tryptic peptides were analyzed by nLC-MS, and the expression of PKP2 and DSG2 proteins was normalized to expression of the 10 most abundant proteins in the corresponding gel piece.
Immunohistochemistry of Cardiac Tissue
Formalin-fixed, paraffin-embedded endomyocardial biopsies obtained from the right ventricular (RV) septum underwent staining with PKP2 and DSG2 antibodies by immunohistochemistry (IHC) as previously described. 5 In addition, septal tissue from the explanted heart mentioned above was IHC stained using antibodies against DSP1+2, JUP, connexin 43 (CX43), N-cadherin, and DSC2. 5 Cardiac tissue of mutation-negative family members (n=2) and individuals who had died from noncardiac causes were used as controls (n=2). Microscopy was performed by 2 experienced cardiovascular pathologists who independently scored immunoreactivity as normal, reduced, or absent.
Statistics
Normality distribution of the data variables was tested by inspection of histograms and quantile-quantile plots, and variance homogeneity was tested by Bartlett test. Normally distributed variables were expressed as mean± SD, and differences between group means were tested using the Student t test. In case of variance inhomogeneity, logarithmic transformation was applied, and if statistical assumptions were then fulfilled, differences between group means were tested using the Student t test. A 2-sided P value <0.05 was considered significant. Logarithmic transformed variables were expressed as median±interquartile range (IQR) on a linear scale. GraphPad Prism software was used for all statistical analyses.
Results
A data section including all sequencing data is available in the Data Supplement.
Characteristics of PKP2 Mutation Carriers
Twelve of 71 index patients were shown to carry diseaseassociated mutations within PKP2 (Tables I and II in the Data Supplement). Nine of these patients had PKP2 mutations in isolation, which were predicted to cause a PTC in the reading frame. The remaining 3 index patients had Table I in the Data Supplement). Familial occurrence of the disease was present in 58% of the families in which 1 or several family members fulfilled diagnostic criteria for AC ( Figure 1 ). Among 20 family members with PKP2 mutations, 7 fulfilled diagnostic Task Force criteria, 5 had borderline signs of the condition, whereas 8 individuals were nonpenetrant ( Figure 1 , Table I in the Data Supplement).
In family 68, the index patient, II-1, underwent cardiac transplantation at the age of 53 years because of end-stage failure of the RV ( Figure 1B) . He was shown to carry a recognized PKP2-p.R79X nonsense mutation in addition to a DSG2-c.1880-1G>A splice site mutation. A similar DSG2 mutation within the same codon (c.1880-2A>G) has previously been shown to activate a cryptic splice site in exon 13 and cause a 38-bp deletion in addition to the introduction of a PTC further downstream of exon 13. 28 The son of the index patient was diagnosed with AC at the age of 18 years, and genetic investigations showed that he had inherited both mutations ( Figure 1B) .
The index patient of family 46, III-3, carried a novel base substitution in the start codon of PKP2 (c.1A>T) and a p.D264E missense variant in the DSG2 gene. The PKP2 variant was classified as pathogenic because it was likely to impair initiation of gene translation. 27 The DSG2 variant was considered to be of unknown significance because it has only been reported in 2 patients with AC previously without evidence of segregation although it was absent in >10 000 Exome Sequencing Project control alleles. 7 A 76-year-old brother (III-1) of the index patient did also carry both mutations ( Figure 1B) . He had T-wave inversion in right precordial leads, a dilated RV with an aneurysm, and fibrofatty replacement in endomyocardial biopsies. Although he remained asymptomatic, he had frequent episodes of nonsustained ventricular tachycardia. His 85-yearold maternal aunt was also a digenic mutation carrier with a mildly dilated RV and an apical aneurysm. She was considered to have borderline AC, whereas her 57-yearold son (III-12), who also carried both mutations, had no signs or symptoms of the condition ( Table I in the Data Supplement). 21 All relatives who were carriers of single mutations had normal phenotypes.
The male index patient of family 76, II-2, carried a PKP2-p. P103T and a DSC2-p.T358I missense variant ( Figure 1B ). There was no family history of AC, and clinical investigations of 3 first-degree relatives were normal ( Figure 1B) . Because both variants were present in the Exome Sequencing Project cohort with minor allele frequencies of 0.019% and 0.093%, respectively, they were considered to be of unknown significance.
Investigations of Intercalated Disc Proteins in the Myocardium of an Explanted Heart From a Digenic Mutation Carrier of PKP2-p.R79X and DSG2-c.1880-1G>A
Histological examination of the explanted myocardium of 68/ II-1 showed transmural fibrofatty replacement of a grossly dilated RV and patchy fibrotic areas of a left ventricle with normal cavity dimensions (Figure 2A ). Western blotting (WB) of a snap-frozen myocardial sample from the left ventricular septum demonstrated that the expression of both PKP2 and DSG2 was reduced by 50% compared with myocardial samples from 2 normal donor hearts ( Figure 2C and 2D) . Furthermore, WB using different PKP2 and DSG2 antibodies with C-and N-terminal epitopes did not detect any truncated PKP2 or DSG2 proteins. The protein expression of DSC2 was diminished by 50%, whereas JUP and N-cadherin expression was reduced by 25%. The expression of DSP was normal; however, a modest (1.6-fold) upregulation of connexin 43 and a substantial higher proportion of less phosphorylated connexin 43 (≈6-fold increase) were detected (Figure 2E-2G ). IHC staining of myocardial samples from the septum indicated a lower expression of PKP2, DSG2, and DSC2 in the patient with AC, whereas expression of JUP, DSP, CX43, and N-cadherin was the same as in control samples ( Figure 2H ).
Immunohistochemistry of Endomyocardial Biopsies From PKP2 Mutation Carriers
PKP2 expression in RV biopsies from index patients (n=9) and affected family members (n=2) was investigated by IHC. Control samples were available from 2 WT family members and 2 deceased individuals who died of noncardiac causes ( Figure 3A ). PKP2 immunoreactivity indicated that PKP2 expression was reduced in 6 of 7 biopsies from individuals with different PTC mutations in the PKP2 gene ( Figure 3A and 3B). No significant reduction in PKP2 expression was observed in samples from individuals carrying the c.1A>T mutation and the p.P103T variant ( Figure 3B ). DSG2 expression was reduced in samples of DSG2-c.1880-1G>A mutation carriers, whereas DSG2 immunoreactivity seemed normal in carriers of the DSG2-p.D264E mutation ( Figure 3C ).
PKP2 Gene Expression in Cultured Keratinocytes of PKP2 Mutation Carriers
PKP2 gene expression was estimated by quantitative reverse transcriptase polymerase chain reaction in primary keratinocytes from PKP2 mutation carriers (n=11) and WT controls (n=7; Figure 4A ). The median PKP2 gene expression was reduced by 53% in cells carrying PTC mutations (n=9) compared with WT cells (n=7): 0.37 (IQR, 0.19-0.45) versus 0.84 (IQR, 0.63-1.50; P<0.0005, t test). In contrast, keratinocytes carrying c.1A>T (n=3) and p.P103T (n=2) missense variants displayed the same PKP2 gene transcript level expression as WT cells, suggesting that both alleles were expressed normally ( Figure 4A and Figure III 
PKP2 Protein Expression in Cultured Keratinocytes of PKP2 Mutation Carriers
Cytoskeletal proteins were extracted from cultured keratinocytes of index patients and analyzed by WB ( Figure 4B and 4C). The median expression of PKP2 protein in PTC mutation carriers was reduced by 59% (n=9) in comparison with WT individuals (n=7): 0.31 (IQR, 0.26-0.50) versus 0.76 (IQR, 0.69-1.51; P=0.001, t test; Figure 4B and 4C). WB using 
WB and nLC-MS of Desmosomal Proteins in Cultured Keratinocytes of Digenic Mutation Carriers
Keratinocyte cultures were established from mutation carriers and WT individuals of family 46, 68, and 76 ( Figure 5 ). By use of WB, it was estimated that PKP2 expression was decreased by 50% in PKP2-c.1A>T (n=3) and PKP2-p.R79X cultures (n=2) compared with WT (n=6). In contrast PKP2-p.P103T cultures (n=2) expressed normal amounts of PKP2 protein ( Figure 5A (Table III and Figure VI in the Data Supplement). These analyses showed that PKP2 and DSG2 expression was reduced by 50% in keratinocyte cultures carrying truncating mutations (PKP2-c.1A>T, PKP2-p.R79X, DSG2-c.1880-1G>A). Mass spectrometry protein expression analysis of cultures carrying missense mutations (PKP2-p.P103T, DSG2-p. D264E) showed a reduction in the total amount of these proteins in mutation carriers compared with WT samples (Figure 5D and 5E ). nLC-MS of trypsin-cleaved DSG2 protein identified both the WT peptide (DSG2 262-275, WT ) and the corresponding variant peptide (DSG2 262-275, MUT ) in heterozygous p.D264E samples (n=3). Consistent with WB and total protein quantification by MS, the amount of DSG2 262-275, MUT comprised only ≈26% of the total amount of DSG2 protein, suggesting that the DSG2-p.D264E variant protein displays decreased stability.
Discussion
Although myocardial and epidermal tissues have different mechanical properties, the stability of both tissues is dependent on a proper intercellular adhesion maintained by desmosomal protein complexes. The fact that keratinocytes express all the cardiac isoforms of desmosomal proteins makes these cells an alternative source to study desmosomal mutations. Because transcript and protein quality control mechanisms are evolutionary conserved entities in mammalian cells, a similar cellular response to mutations in these tissues would be expected. We therefore used cultured keratinocytes as model to study the expression of PKP2 in mutation carriers.
Protein expression studies of the myocardium from an explanted heart of a patient with AC with PTC mutations in the genes for PKP2 and DSG2 demonstrated haploinsufficiency of both corresponding proteins. We proceeded with studies in keratinocytes of the same individual and a family member with similar mutations and for the first time demonstrated that myocardial haploinsufficiency of PKP2 and DSG2 is mirrored by similar changes in keratinocytes, as suggested by our previous studies in keratinocytes from other patients with AC. 5, 24 The presence of mutations in desmosomal genes or an unknown gene may affect expression of protein components of the desmosome. Unfortunately, individuals with single mutations were not available to study the isolated effect of the mutations. Our findings are however in accordance with previous results from human myocardial samples. A previous immunofluorescence study by Noorman et al 16 indicated reduced PKP2 expression in individuals carrying the PKP2-p.R79X mutation in isolation. Furthermore, Gehmlich et al 27 demonstrated reduced expression by WB of DSG2 but not of PKP2 in the myocardium of a patient carrying a DSG2 null mutation leading to haploinsufficiency. The fact that the patients in family 68 had haploinsufficiency for both PKP2 and DSG2 may well explain the severe and early-onset phenotype observed in the family.
Subsequent keratinocyte investigations in additional PKP2 patients with various PTC mutations showed that PKP2 gene and protein expression in patients with truncating mutations was reduced by >50% in the absence of detectable C-terminal truncated PKP2 proteins. Furthermore, IHC of endomyocardial biopsies showed a reduced PKP2 immunoreactivity of the same patients.
Although these findings adhere to previous observations, the IHC technique has several limitations.. 15, 16 The presence of fibrotic or fibrofatty replacement changes in nearly all biopsies may have influenced the expression of intercalated disc proteins. Furthermore, investigation of protein expression in endomyocardial biopsies by IHC is only semiquantitative, and the results may be biased by several factors such as variations in section thickness, composition of tissue elements, fixation, shrinkage, and observer bias. However, the results are well in accordance with the fact that the introduction of a PTC in the reading frame apart from few exceptions activates the nonsense-mediated mRNA decay mechanism and thereby causes haploinsufficiency. 29, 30 In family 46, 2 patients with AC carried a novel PKP2c.1A>T mutation and a previously reported DSG2-p.D264E variant of unknown significance. 7 Gene expression studies indicated that the PKP2-c.1A>T transcript was expressed in the same amount as WT PKP2 mRNA, whereas protein investigations showed a decreased PKP2 protein expression. These observations suggested that the mutation abolished initiation of translation and thereby caused haploinsufficiency. The findings were further supported by the fact that no N-terminal truncated PKP2 protein was detected although theoretically it would be possible to initiate translation of mutated PKP2 at a downstream methionine start codon at amino acid position 110. The DSG2-p.D264E variant was associated with a lower expression of total DSG2 protein although subsequent nLC-MS experiments detected the DSG2-p.D264E variant peptide in cytoskeletal protein fractions. These findings indicated 2 possible effects of this variant: (1) loss of function attributable to decreased amounts of DSG2 protein and (2) a dominant negative effect attributable to incorporation of mutated protein in desmosomal complexes. Interestingly, none of the individuals carrying the p.D264E variant in isolation expressed phenotypic features of AC, which suggested a possible modifying effect of this variant.
In family 76, 2 rare desmosomal missense variants of unknown significance were identified. The expression of PKP2 and DSC2 protein in keratinocytes were normal and suggested that the PKP2-p.P103T and DSC2-p.T358I variant proteins were likely to be coexpressed with the corresponding WT proteins. These results were in accordance with a recent transfection study using a squamous carcinoma cell line in which PKP2 protein missense variants were shown to be incorporated into desmosomal junctions and impair the interaction with DSP. 17 Further clarification of the pathogenic impact of these missense variants would require segregation analysis of additional affected individuals with the same genotype, and, finally, it is possible that the phenotype is caused by an unknown genetic variant.
Ventricular arrhythmias are common in AC, and desmosomal mutations may cause alterations in the molecular composition of the intercalated discs and thereby influence the electric stability of the myocardium. 15, 27, 31 Previous studies have shown that in vitro silencing of the PKP2 gene in cultured myocytes is associated with a redistribution of the major gap junction protein connexin 43 and a decreased sodium influx mediated by voltage-gated sodium channels. 13, 32 In this study, we showed that the amount of dephosphorylated connexin 43 was increased in an explanted heart of a PKP2 haploinsufficient patient, with a substantial shift toward dephosphorylated protein. This observation was in accordance with previous findings in patients with AC, including a patient with DSG2 haploinsufficiency. 16, 27 One previous study of transfected HeLa cell lines has suggested that increased amounts of dephosphorylated connexin 43 may lead to slower conduction velocities. 33 It is therefore likely that haploinsufficiency of desmosomal proteins in patients with AC may explain the increased risk of ventricular arrhythmias. 34 In conclusion, the results of the present study indicate that levels of myocardial expression of desmosomal proteins in patients with AC are mirrored by similar changes in their keratinocytes. It is therefore possible to use keratinocyte cultures from affected individuals as a model system to characterize the likely cardiac impact of desmosomal gene mutations in AC. By use of this approach, we have shown that PKP2 mutations introducing a PTC are associated with haploinsufficiency. Although mutation carriers exhibited the same abnormal protein expression profile, their phenotype varied considerably and included entirely healthy individuals. These findings substantiate that AC is a condition with a complex mode of inheritance and that compound heterozygous and digenic sequence variants in recognized and yet to be discovered genes are likely to modify the phenotypic appearance of mutation carriers. 
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